Navigation Links
Florida Legislature Refuses to Limit Mercury in Vaccines
Date:5/9/2011

SILVER SPRING, Md., May 9, 2011 /PRNewswire-USNewswire/ – CoMeD – On Friday, May 6, 2011, in Tallahassee, Florida, a Republican State Senator filed an amendment to regulate vaccines containing mercury in Florida.  The amendment would have made it illegal to buy, sell, manufacture, deliver, import, administer or distribute any vaccine that contained more than 0.3 micrograms of organic or inorganic mercury per milliliter for children younger than age 7 or pregnant women.  Despite support for this vaccine safety measure, the amendment was voted down.

Concern continues that mercury, in the form of Thimerosal, is still used in vaccines at all because mercury is recognized to cause cancer, genetic mutations, miscarriages and birth defects.  Today, 2-phenoxyethanol, an economical, less toxic alternative to Thimerosal, has been used as a preservative in some formerly Thimerosal-preserved U.S. vaccines licensed since 2001, because of the 1999 call by the U.S. Public Health Services and the American Academy to remove Thimerosal from U.S. vaccines "as soon as possible."

This amendment would have afforded pregnant women and young children significant protection from mercury exposure through flu shots, where most doses are still Thimerosal-preserved and are routinely recommended for administration to children and pregnant women.

In March 2009, the Governor's Task Force on Autism Spectrum Disorders in the State of Florida issued a report recommending that Florida "explore the prohibition of the purchase and administration of all mercury-containing (e.g., Thimerosal) vaccines."  The report also acknowledged, "…new, peer-reviewed scientific literature…suggests a causal relationship between mercury exposure from Thimerosal-containing vaccines and autism."

Ignoring that report and the ever-increasing evidence of harm, Florida Senator Nan Rich (D-Sunrise), who opposed the amendment, stated, "All the credible evidence out there shows that Thimerosal has nothing to do with autism," as if other proven harms linked to Thimerosal in vaccines do not matter. Senator Alan Hays (R-Umatilla) erroneously claimed mercury had been removed from all vaccines.  A prominent Tallahassee lobbyist reported that he had never, in his 20-year career, seen such as swarm of pharmaceutical industry lobbyists descend on Tallahassee in opposition to a bill.

The Coalition for Mercury-free Drugs (CoMeD) continues to publicize new studies that prove organic mercury in vaccines and elemental mercury in "silver-amalgam" dental fillings, are associated with neurological deficits such as autism, language delay and tics in children, and Alzheimer's in adults. A new study from Behavioural Brain Research concluded, "…existing research calls for prudence and removal of (Thimerosal) from all medicinal, cosmetic and food products designated for children and pregnant women."  

Citing a recent study from the University of Brazil, which recognized both the benefit of vaccines and the unnecessary risk of Thimerosal, Rev. Lisa K. Sykes, President of CoMeD, observed, "Putting poison in a baby shot is ludicrous, especially when we know mercury is an unwarranted vaccine ingredient.  The Florida Senators who voted this amendment down are clearly more interested in the wellbeing of the lobbyists and the pharmaceutical industry than in the wellbeing of Florida's children."


'/>"/>
SOURCE Coalition for Mercury-Free Drugs (CoMeD)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Saving Lives of Florida Residents Who Develop Skin Cancer Each Year: The Key is Early Detection and Treatment
2. Nobel Laureate Dr. Gunter Blobel to Speak at Florida Atlantic University
3. Anpath Group, Inc. Announces Approval of its Disinfectant by the State of Florida
4. CVBT Opens Florida and Arizona Sites for Its ACORD Phase II Heart Trial
5. St. Anthonys Hospital Offers First Ambient MRI In Florida
6. New Florida Law Allows Use of Instant Drug Tests On the Job Site
7. Access MediQuip Moves Company Headquarters to Lake Mary, Florida
8. Prescription Assistance Arrives in Jacksonville, Florida
9. Varian Medical Systems Showcases Advanced Radiotherapy and Brachytherapy Products at ACRO 2010, February 25-27, Florida, Booth No. 34-35
10. IVF FLORIDA Reproductive Associates Partners with The University of Miami School of Medicine and Jackson Memorial Health
11. Alliance Imaging Offers Mobile Positron Emission Mammography (PEM) Imaging to its Florida Customers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... 2017  AcelRx Pharmaceuticals, Inc. (Nasdaq: ... the development and commercialization of innovative therapies for ... Vincent J. Angotti has been appointed ... company,s board of directors, effective Monday, March 6, ... experience leading executive and commercial teams at public ...
(Date:2/16/2017)... , Feb. 16, 2017  Prescription pain medications ... department visit are necessary for long-term opioid use to ... Feb. 16 th edition of The New ... "Emergency physicians see more patients in acute pain than ... Parker , MD, FACEP, president of the American College ...
(Date:2/16/2017)... Research and Markets has announced the addition of the ... Function, Application, Cancer Type, Technology - Forecast to 2025" report ... ... grow at a CAGR of around 28.6% over the next decade ... Some of the prominent trends that the market is witnessing include ...
Breaking Medicine Technology:
(Date:2/18/2017)... ... February 17, 2017 , ... Focused ... innovation in the industry, according to the recent NEJM Catalyst Insights Report on ... of the NEJM Catalyst Insights Council, a qualified group of U.S. executives, clinical ...
(Date:2/18/2017)... ... 2017 , ... A new directory from the Senior Veterans ... connect elderly veterans of America's armed forces to a range of senior care ... on this year's increase in the Veterans Pension with Aid & Attendance for ...
(Date:2/17/2017)... ... 2017 , ... For the first time, International Scholarship and ... floor for the 2017 HIMSS Conference & Exhibition at the Orange ... than 40,000 healthcare industry professionals are expected at the conference, where they will ...
(Date:2/17/2017)... ... February 17, 2017 , ... Access today ... Exhibition in Orlando, Fla., February 19-23. Visitors to the company’s booth (#1778) will ... used electronic patient signatures solution in healthcare . , Since it first ...
(Date:2/17/2017)... ... February 17, 2017 , ... Cancer diagnostics workflow solution provider ... 20 – 22 in San Francisco. As part of the Tri-Conference expo, which ... workflow solution, as well as its new precision medicine platform, “Crosswalk Insight: Oncology™.” ...
Breaking Medicine News(10 mins):